Severe hypernatremia in deceased liver donors does not impact early transplant outcome

Richard Mangus, Jonathan A. Fridell, Rodrigo M. Vianna, Martin L. Milgrom, Paul Chestovich, Chelsea Vandenboom, A. Joseph Tector

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background. There may be an increased risk of primary nonfunction in livers procured from donors with hypernatremia. The purported mechanism for this effect is undefined. This study analyzes early graft function for donor livers procured from patients with severe hypernatremia. Methods. The organ procurement records for 1013 consecutive deceased liver donors between 2001 and 2008 were reviewed. Both peak and terminal serum sodium levels were categorized as (1) severe for a level 170 mEq/L or higher, (2) moderate for 160 to 169 mEq/L, and (3) normal for less than 160 mEq/L. Outcomes included 30-day posttransplant alanine aminotransferase and total bilirubin, primary nonfunction, and 30-day and 1-year graft survival. Results. Within the severe hypernatremia group, there were 142 (peak) and 50 (terminal) donors, whereas the moderate group had 233 (peak) and 162 (terminal) donors. The study groups did not differ in recipient age, model for end-stage liver disease score, steatosis, and ischemia times for the peak or terminal serum sodium groups. The differing levels of hypernatremia severity did not differ importantly, for peak or terminal serum sodium, in posttransplant alanine aminotransferase or total bilirubin, or the risk of intraoperative death and primary nonfunction. Thirty-day and 1-year graft survival did not demonstrate a negative impact from donor hypernatremia. Conclusions. Posttransplant measures of early liver function and risk of failure, up to 1-year posttransplant, did not differ significantly based on peak or terminal donor serum sodium levels. These results suggest that donor serum sodium level likely has little clinical impact on posttransplant liver function.

Original languageEnglish
Pages (from-to)438-443
Number of pages6
JournalTransplantation
Volume90
Issue number4
DOIs
StatePublished - Aug 27 2010

Fingerprint

Hypernatremia
Tissue Donors
Transplants
Liver
Sodium
Serum
Graft Survival
Alanine Transaminase
Bilirubin
End Stage Liver Disease
Tissue and Organ Procurement
Ischemia

Keywords

  • Extended criteria donor
  • Graft survival
  • Hypernatremia
  • Orthotopic liver transplant
  • Transplant outcomes

ASJC Scopus subject areas

  • Transplantation

Cite this

Mangus, R., Fridell, J. A., Vianna, R. M., Milgrom, M. L., Chestovich, P., Vandenboom, C., & Tector, A. J. (2010). Severe hypernatremia in deceased liver donors does not impact early transplant outcome. Transplantation, 90(4), 438-443. https://doi.org/10.1097/TP.0b013e3181e764c0

Severe hypernatremia in deceased liver donors does not impact early transplant outcome. / Mangus, Richard; Fridell, Jonathan A.; Vianna, Rodrigo M.; Milgrom, Martin L.; Chestovich, Paul; Vandenboom, Chelsea; Tector, A. Joseph.

In: Transplantation, Vol. 90, No. 4, 27.08.2010, p. 438-443.

Research output: Contribution to journalArticle

Mangus, R, Fridell, JA, Vianna, RM, Milgrom, ML, Chestovich, P, Vandenboom, C & Tector, AJ 2010, 'Severe hypernatremia in deceased liver donors does not impact early transplant outcome', Transplantation, vol. 90, no. 4, pp. 438-443. https://doi.org/10.1097/TP.0b013e3181e764c0
Mangus R, Fridell JA, Vianna RM, Milgrom ML, Chestovich P, Vandenboom C et al. Severe hypernatremia in deceased liver donors does not impact early transplant outcome. Transplantation. 2010 Aug 27;90(4):438-443. https://doi.org/10.1097/TP.0b013e3181e764c0
Mangus, Richard ; Fridell, Jonathan A. ; Vianna, Rodrigo M. ; Milgrom, Martin L. ; Chestovich, Paul ; Vandenboom, Chelsea ; Tector, A. Joseph. / Severe hypernatremia in deceased liver donors does not impact early transplant outcome. In: Transplantation. 2010 ; Vol. 90, No. 4. pp. 438-443.
@article{c9ebf0345ae548eb9bfdd99220aafc31,
title = "Severe hypernatremia in deceased liver donors does not impact early transplant outcome",
abstract = "Background. There may be an increased risk of primary nonfunction in livers procured from donors with hypernatremia. The purported mechanism for this effect is undefined. This study analyzes early graft function for donor livers procured from patients with severe hypernatremia. Methods. The organ procurement records for 1013 consecutive deceased liver donors between 2001 and 2008 were reviewed. Both peak and terminal serum sodium levels were categorized as (1) severe for a level 170 mEq/L or higher, (2) moderate for 160 to 169 mEq/L, and (3) normal for less than 160 mEq/L. Outcomes included 30-day posttransplant alanine aminotransferase and total bilirubin, primary nonfunction, and 30-day and 1-year graft survival. Results. Within the severe hypernatremia group, there were 142 (peak) and 50 (terminal) donors, whereas the moderate group had 233 (peak) and 162 (terminal) donors. The study groups did not differ in recipient age, model for end-stage liver disease score, steatosis, and ischemia times for the peak or terminal serum sodium groups. The differing levels of hypernatremia severity did not differ importantly, for peak or terminal serum sodium, in posttransplant alanine aminotransferase or total bilirubin, or the risk of intraoperative death and primary nonfunction. Thirty-day and 1-year graft survival did not demonstrate a negative impact from donor hypernatremia. Conclusions. Posttransplant measures of early liver function and risk of failure, up to 1-year posttransplant, did not differ significantly based on peak or terminal donor serum sodium levels. These results suggest that donor serum sodium level likely has little clinical impact on posttransplant liver function.",
keywords = "Extended criteria donor, Graft survival, Hypernatremia, Orthotopic liver transplant, Transplant outcomes",
author = "Richard Mangus and Fridell, {Jonathan A.} and Vianna, {Rodrigo M.} and Milgrom, {Martin L.} and Paul Chestovich and Chelsea Vandenboom and Tector, {A. Joseph}",
year = "2010",
month = "8",
day = "27",
doi = "10.1097/TP.0b013e3181e764c0",
language = "English",
volume = "90",
pages = "438--443",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Severe hypernatremia in deceased liver donors does not impact early transplant outcome

AU - Mangus, Richard

AU - Fridell, Jonathan A.

AU - Vianna, Rodrigo M.

AU - Milgrom, Martin L.

AU - Chestovich, Paul

AU - Vandenboom, Chelsea

AU - Tector, A. Joseph

PY - 2010/8/27

Y1 - 2010/8/27

N2 - Background. There may be an increased risk of primary nonfunction in livers procured from donors with hypernatremia. The purported mechanism for this effect is undefined. This study analyzes early graft function for donor livers procured from patients with severe hypernatremia. Methods. The organ procurement records for 1013 consecutive deceased liver donors between 2001 and 2008 were reviewed. Both peak and terminal serum sodium levels were categorized as (1) severe for a level 170 mEq/L or higher, (2) moderate for 160 to 169 mEq/L, and (3) normal for less than 160 mEq/L. Outcomes included 30-day posttransplant alanine aminotransferase and total bilirubin, primary nonfunction, and 30-day and 1-year graft survival. Results. Within the severe hypernatremia group, there were 142 (peak) and 50 (terminal) donors, whereas the moderate group had 233 (peak) and 162 (terminal) donors. The study groups did not differ in recipient age, model for end-stage liver disease score, steatosis, and ischemia times for the peak or terminal serum sodium groups. The differing levels of hypernatremia severity did not differ importantly, for peak or terminal serum sodium, in posttransplant alanine aminotransferase or total bilirubin, or the risk of intraoperative death and primary nonfunction. Thirty-day and 1-year graft survival did not demonstrate a negative impact from donor hypernatremia. Conclusions. Posttransplant measures of early liver function and risk of failure, up to 1-year posttransplant, did not differ significantly based on peak or terminal donor serum sodium levels. These results suggest that donor serum sodium level likely has little clinical impact on posttransplant liver function.

AB - Background. There may be an increased risk of primary nonfunction in livers procured from donors with hypernatremia. The purported mechanism for this effect is undefined. This study analyzes early graft function for donor livers procured from patients with severe hypernatremia. Methods. The organ procurement records for 1013 consecutive deceased liver donors between 2001 and 2008 were reviewed. Both peak and terminal serum sodium levels were categorized as (1) severe for a level 170 mEq/L or higher, (2) moderate for 160 to 169 mEq/L, and (3) normal for less than 160 mEq/L. Outcomes included 30-day posttransplant alanine aminotransferase and total bilirubin, primary nonfunction, and 30-day and 1-year graft survival. Results. Within the severe hypernatremia group, there were 142 (peak) and 50 (terminal) donors, whereas the moderate group had 233 (peak) and 162 (terminal) donors. The study groups did not differ in recipient age, model for end-stage liver disease score, steatosis, and ischemia times for the peak or terminal serum sodium groups. The differing levels of hypernatremia severity did not differ importantly, for peak or terminal serum sodium, in posttransplant alanine aminotransferase or total bilirubin, or the risk of intraoperative death and primary nonfunction. Thirty-day and 1-year graft survival did not demonstrate a negative impact from donor hypernatremia. Conclusions. Posttransplant measures of early liver function and risk of failure, up to 1-year posttransplant, did not differ significantly based on peak or terminal donor serum sodium levels. These results suggest that donor serum sodium level likely has little clinical impact on posttransplant liver function.

KW - Extended criteria donor

KW - Graft survival

KW - Hypernatremia

KW - Orthotopic liver transplant

KW - Transplant outcomes

UR - http://www.scopus.com/inward/record.url?scp=77955984334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955984334&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3181e764c0

DO - 10.1097/TP.0b013e3181e764c0

M3 - Article

C2 - 20679966

AN - SCOPUS:77955984334

VL - 90

SP - 438

EP - 443

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 4

ER -